CORIHA: Cementless One-stage Revision of the Chronic Infected Hip Arthroplasty

Sponsor
University of Aarhus (Other)
Overall Status
Completed
CT.gov ID
NCT01015365
Collaborator
(none)
56
8
1
96
7
0.1

Study Details

Study Description

Brief Summary

The investigators hypothesise that cementless one-stage exchange revision surgery can be performed in patients with chronically infected hip replacement with substantial benefits for the patients, in terms of fast rehabilitation, low re-revision rates and good long term results.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Cementless one-stage surgical revision
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
56 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Cementless One-stage Revision in Fast-track Setting of the Chronic Infected Hip Arthroplasty
Study Start Date :
Nov 1, 2009
Actual Primary Completion Date :
Oct 1, 2016
Actual Study Completion Date :
Nov 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Other: Surgical revision

Surgical cementless One-stage revision of the chronic infected hip arthroplasty

Procedure: Cementless one-stage surgical revision
A Cementless one-stage surgical revision is to be performed for all included in the cohort.

Outcome Measures

Primary Outcome Measures

  1. re-infection [2 years]

Secondary Outcome Measures

  1. Revision for other cause than infection [2 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient with clinical signs of infection for more than 4 weeks, arising from total hip arthroplasty (primary and revision), resurfacing hip arthroplasty or hemi-hip arthroplasty

  • Informed oral and written consent given

Exclusion Criteria:
  • Life expectancy under 2 years

  • Cognitive dysfunction

  • Pre-operative unwillingness to receive blood

  • Intravenous drug abuse

  • Alcoholism

  • Immunocompromised patients

  • Patients receiving immunosuppressive medication

  • Ongoing systemic inflammatory disease

  • Poorly regulated diabetes mellitus

  • Renal failure (requiring dialysis)

  • Acute systemic inflammatory response syndrome with proven infection (sepsis)

  • Signs of coexisting active long-term local infection (i.e. endocarditis)

  • Previous two-stage revision of hip arthroplasty due to ipsilateral chronic infection (regardless of symptom free interval) or contralateral chronic infection (within the last 2 years).

  • < 6 weeks since last surgery of the affected hip

  • If definition of infection is not fulfilled: infection defined as Culture positive: ≥ 3 positive intraoperative cultures (tissue biopsies a.m. Kamme-Lindberg) Culture negative: < 3 positive intraoperative cultures (tissue biopsies a.m. Kamme-Lindberg) + Chronic fistula with history of previous or existing secretion or Positive cultures in pre-operatively joint fluid aspiration with other clinical signs of infection or Visual pus or purulent fluid during exchange procedure with clinical signs of infection

Contacts and Locations

Locations

Site City State Country Postal Code
1 Orthopaedic Center, Alborg sygehus, Aarhus Universityhospital Aalborg Denmark 9000
2 Orthopaedic department, Aarhus Universityhospital Aarhus Denmark 8000
3 Gentofte Hospital Hellerup Denmark 2900
4 Orthopaedic department, Hvidovre Hospital Hvidovre Denmark 2650
5 Regionalhospital Silkeborg Silkeborg Denmark 8600
6 Sønderborg Hospital Sønderborg Denmark 6400
7 Vejle Hospital Vejle Denmark 7100
8 Regional Hospital Viborg Viborg Denmark 8800

Sponsors and Collaborators

  • University of Aarhus

Investigators

  • Study Chair: Kjeld Soballe, Prof. D.Msc., Lundbeckfoundation center for fast-track hip and knee surgery
  • Principal Investigator: Jeppe Lange, M.D., Lundbeckfoundation center for fast-track hip and knee surgery

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
University of Aarhus
ClinicalTrials.gov Identifier:
NCT01015365
Other Study ID Numbers:
  • CORIHA
First Posted:
Nov 18, 2009
Last Update Posted:
Nov 20, 2017
Last Verified:
Nov 1, 2017

Study Results

No Results Posted as of Nov 20, 2017